Truth in Health Joins Patients1st Coalition & MAHA
Truth in Health joins the Patients1st Coalition, helping bridge science, prevention, and public health conversations shaping America’s future.
Truth in Health joins the Patients1st Coalition, helping bridge science, prevention, and public health conversations shaping America’s future.
A Global Call to Action for Human Health
Today, our world faces a preventable crisis rooted in a silent but widespread nutritional imbalance — a severe disruption in Omega-3 and Omega-6 fatty acid ratios. This imbalance affects cellular function, immunity, inflammation, neurodevelopment, and overall biological resilience. Scientists, clinicians, biochemists, metabolic researchers, and medical practitioners across the globe have independently raised concern about this issue, yet it remains insufficiently addressed at national and international policy levels.
The Wellness Alliance: Truth in Health Association 501(c)(3) is coordinating this Open Letter to bring together global experts and concerned citizens in unified scientific voice. This statement will be formally delivered to:
The purpose of this initiative is to request formal acknowledgment, scientific review, and coordinated policy action regarding the essential fatty acid composition of modern diets and its profound impact on global health.
Why This Matters
For decades, populations worldwide have drifted into a state of nutritional malregulation created by:
These shifts can contribute to:
Although abundant scientific evidence exists across lipid biology, neuroscience, developmental physiology, and metabolic research, public policy guidance has not kept pace with the science.
This global Open Letter calls for evidence-based leadership to reassess essential fatty acid exposures across populations and align food systems with human biological needs.
Add Your Voice
Professionals, scientists, clinicians, academics, policymakers, and members of the public are invited to sign.
Your signature will be included in the official submission and public signatory list.
Please review the scientific statement below and add your name using the form provided.
To Heads of State, Ministers of Health, Directors of International and Regional Health Agencies, and Leaders of Global Food and Agriculture Systems:
We, the undersigned scientists and clinicians working in lipid biology, nutrition, metabolism, developmental neuroscience, resolution pharmacology, and the endocannabinoid system, write to draw your attention to a critical but addressable aspect of modern human nutrition: the altered intake and biological handling of essential fatty acids, particularly omega-3 and omega-6 polyunsaturated fatty acids (PUFAs), and their impact on human physiology across the life course.
Our aim is not to declare a simple “villain” nutrient, but to underscore that current dietary patterns and food systems have created a biochemical milieu without historical precedent, and that this milieu has profound implications for inflammation, neurodevelopment, cardiometabolic disease, and healthy aging. We believe this warrants coordinated national and international assessment, guidance, and education.
There is broad scientific agreement that:
Essential fatty acids participate in:
When intake patterns and tissue composition of these fatty acids are substantially shifted— whether by high LA intake, low EPA/DHA intake, altered animal feeds, or ultra-processed dietary patterns—there is concern that inflammatory responses, neurodevelopmental trajectories, and cardiometabolic risk profiles may be negatively affected.
These issues affect educational attainment, workforce productivity, and long-term health expenditure trajectories of every nation.
The undersigned acknowledge ongoing scientific debate, including:
These open questions strengthen rather than weaken the case for coordinated action. They highlight how much is at stake and how much clarity is still needed.
This statement is not a call for simplistic dietary prescriptions or for blaming any single nutrient. It is a call for recognition that modern fatty acid patterns differ substantially from those that shaped human physiology; for transparent assessment of their relationship to disease burden and human potential; and for leadership in aligning agriculture, food policy, and health systems with biological needs.
The potential gains in health, cognition, resilience, and national prosperity could be generational.
Respectfully,
Charles “Chip” Paul
ECS Theorist & Public Health Advocate
Convenor, Global Scientific Statement on Essential Fatty Acids,
Lipid Composition & Human Health
Prof. Philip C. Calder, PhD, RNutr, FSB, FAfN
Professor of Nutritional Immunology
Faculty of Medicine
University of Southampton
Southampton, United Kingdom
Hagler Fellow
College of Medicine
Texas A&M University
College Station, Texas, USA
Prof. Michael A. Crawford, PhD, FRSB, FRSC, FRCPath
Visiting Professor, Department of Metabolism, Digestion and Reproduction
Chelsea & Westminster Hospital Campus
Imperial College London
United Kingdom
Prof. Jesmond Dalli, PhD, FHEA, FRSB, FBPhS
Professor of Molecular Pharmacology
Director, Lipid Mediator Unit
William Harvey Research Institute
Barts and The London School of Medicine and Dentistry
Queen Mary University of London
United Kingdom
Prof. Vincenzo Di Marzo, PhD
Canada Excellence Research Chair, Microbiome–Endocannabinoidome Axis in Metabolic Health
Université Laval, Quebec, Canada
Research Director, Institute of Biomolecular Chemistry
Consiglio Nazionale delle Ricerche (CNR), Italy
Prof. Jörg (Jürg) Gertsch, PhD
Professor, Institute of Biochemistry and Molecular Medicine
University of Bern
Switzerland
Prof. William S. Harris, PhD
Founder and President, Fatty Acid Research Institute
Professor of Medicine (Emeritus), Sanford School of Medicine
University of South Dakota
United States
Prof. Daniele Piomelli, PhD, MD (h.c.)
Distinguished Professor of Anatomy & Neurobiology, Biological Chemistry, and Pharmaceutical Sciences
Louise Turner Arnold Chair in the Neurosciences
Director, Center for the Study of Cannabis
University of California, Irvine
United States
Adjunct Professor
University of Vienna
Austria
Prof. Charles N. Serhan, PhD, DSc
Gelman Professor of Anaesthesia (Biochemistry & Molecular Pharmacology)
Director, Center for Experimental Therapeutics and Reperfusion Injury
Brigham and Women’s Hospital
Harvard Medical School
United States
Prof. Clemens von Schacky, MD
Chief Executive Officer, Omegametrix GmbH
Senior Researcher in Preventive Cardiology and Lipidomics
Munich, Germany
SIGN THE OPEN LETTER